Search Results - "Bio, Laura L."

Leveraging antimicrobial stewardship programs in response to the coronavirus disease 2019 (COVID-19) public health emergency by Joerger, Torsten A., Bio, Laura L., Puckett, Lauren M., Schwenk, Hayden T.

“…Abstract The coronavirus disease 2019 (COVID-19) pandemic has strained antimicrobial stewardship programs (ASPs) but offered new opportunities. This review…”
Get full text

Successful enteral administration of crushed posaconazole delayed‐release tablets in children by Bio, Laura L., Hiroshima, Lyndsie, Schwenk, Hayden T., Green, Sean

“…Erratic absorption of posaconazole oral suspension necessitates frequent dosing and administration with meals or supplements. Alternative enteral formulations…”
Get full text

Antifungal stewardship in practice: Insights from a prospective audit and feedback program by Bio, Laura L., Weng, Yingjie, Schwenk, Hayden T.

“…To identify characteristics of antifungal prospective audit and feedback (PAF) and to compare rates of PAF recommendation and acceptance between antifungal and…”
Get full text

Shedding Light on Amoxicillin, Amoxicillin-clavulanate, and Cephalexin Dosing in Children from a Pharmacist's Perspective by Yu, Diana, Bio, Laura L

“…Selection of an antibiotic and dosing regimen requires consideration of multiple factors including microbiological data, site of infection, pharmacokinetics,…”
Get full text

Indication-driven order entry decreases stewardship and pharmacist interventions by Nishiguchi, Jacey L., Bio, Laura L., Cornell, Sean T., Schwenk, Hayden T.

“…Indication-driven order entry (IDOE) was implemented at our pediatric institution for cefazolin, piperacillin-tazobactam, and meropenem; the 3 most intervened…”
Get full text

Prescribing Patterns of Nonrecommended Medications for Children With Acute COVID-19 by Burns, Julianne E, Dahlen, Alex, Bio, Laura L, Chamberlain, Lisa J, Bassett, Hannah K, Ramaraj, Raksha, Schwenk, Hayden T, Teufel, 2nd, Ronald J, Schroeder, Alan R

“…Repurposed medications for acute coronavirus disease 2019 (COVID-19) continued to be prescribed after results from rigorous studies and national guidelines…”
Get full text

Reducing Piperacillin and Tazobactam Use for Pediatric Perforated Appendicitis by Seddik, Talal B., Rabsatt, Lauren A., Mueller, Claudia, Bassett, Hannah K., Contopoulos-Ioannidis, Despina, Bio, Laura L., Anderson, Victor D., Schwenk, Hayden T.

“…Although perforated appendicitis is associated with infectious complications, the choice of antibiotic therapy is controversial. We assess the effectiveness…”
Get full text

Predictors of Antimicrobial Stewardship Program Recommendation Disagreement by Bio, Laura L, Kruger, Jenna F, Lee, Betty P, Wood, Matthew S, Schwenk, Hayden T

“…OBJECTIVETo identify predictors of disagreement with antimicrobial stewardship prospective audit and feedback recommendations (PAFR) at a free-standing…”
Get full text

Hidden No More: Capturing the Full Picture of Prolonged Perioperative Antibiotic Prophylaxis by Schwenk, Hayden T, Bio, Laura L

Get more information

Use of Prospective Audit and Feedback to Reduce Antibiotic Exposure in a Pediatric Cardiac ICU by Schwenk, Hayden T., Kruger, Jenna F., Sacks, Loren D., Wood, Matthew S., Qureshi, Lubna, Bio, Laura L.

“…We sought to determine whether a prospective audit and feedback intervention decreased antibiotic utilization in a pediatric cardiac ICU and to describe the…”
Get full text

Standardization of post‐operative antimicrobials reduced exposure while maintaining good outcomes in pediatric liver transplant recipients by Bio, Laura L., Schwenk, Hayden T., Chen, Sharon F., Conlon, Sarah, Gallo, Amy, Bonham, Clark Andy, Gans, Hayley A.

“…Infections following orthotopic liver transplant (OLT) result in significant morbidity and mortality, warranting careful consideration of risks associated with…”
Get full text

Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients by Schwenk, Hayden T, Bio, Laura L, Kruger, Jenna F, Banaei, Niaz

“…Reliance on tests that detect only the presence of toxigenic Clostridium difficile can result in overdiagnosis and overtreatment of C difficile infection…”
Get full text

Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents by Wolf, Joshua, Abzug, Mark J, Wattier, Rachel L, Sue, Paul K, Vora, Surabhi B, Zachariah, Philip, Dulek, Daniel E, Waghmare, Alpana, Olivero, Rosemary, Downes, Kevin J, James, Scott H, Pinninti, Swetha G, Yarbrough, April, Aldrich, Margaret L, MacBrayne, Christine E, Soma, Vijaya L, Grapentine, Steven P, Oliveira, Carlos R, Hayes, Molly, Kimberlin, David W, Jones, Sarah B, Bio, Laura L, Morton, Theodore H, Hankins, Jane S, Maron, Gabriela M, Timberlake, Kathryn, Young, Jennifer L, Orscheln, Rachel C, Schwenk, Hayden T, Goldman, David L, Groves, Helen E, Huskins, W Charles, Rajapakse, Nipunie S, Lamb, Gabriella S, Tribble, Alison C, Lloyd, Elizabeth C, Hersh, Adam L, Thorell, Emily A, Ratner, Adam J, Chiotos, Kathleen, Nakamura, Mari M

“…Although monoclonal antibody therapies for coronavirus disease 2019 have received emergency use authorization for treatment of adolescents in specified…”
Get full text

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis by Aparicio, Camila, Willis, Zachary I, Nakamura, Mari M, Wolf, Joshua, Little, Cordell, Maron, Gabriela M, Sue, Paul K, Anosike, Brenda I, Miller, Christine, Bio, Laura L, Singh, Prachi, James, Scott H, Oliveira, Carlos R

“…Risk stratification is a cornerstone of the Pediatric Infectious Diseases Society COVID-19 treatment guidance. This systematic review and meta-analysis aimed…”
Get full text

Vancomycin-Induced Nephrotoxicity in Adolescents Receiving Extended Infusion: Case Series by Bio, Laura L, Nadeem, Komal

“…ABSTRACTBecause of concerns of red man syndrome, our institution increased standard vancomycin infusion duration to 90 minutes for 1000-mg doses and 120…”
Get full text

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents by Wolf, Joshua, Abzug, Mark J, Anosike, Brenda I, Vora, Surabhi B, Waghmare, Alpana, Sue, Paul K, Olivero, Rosemary M, Oliveira, Carlos R, James, Scott H, Morton, Theodore H, Maron, Gabriela M, Young, Jennifer L, Orscheln, Rachel C, Schwenk, Hayden T, Bio, Laura L, Willis, Zachary I, Lloyd, Elizabeth C, Hersh, Adam L, Huskins, Charles W, Soma, Vijaya L, Ratner, Adam J, Hayes, Molly, Downes, Kevin, Chiotos, Kathleen, Grapentine, Steven P, Wattier, Rachel L, Lamb, Gabriella S, Zachariah, Philip, Nakamura, Mari M

“…Abstract Background Starting in November 2020, the US Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel…”
Get full text

Incidence of Vancomycin-Induced Red Man Syndrome in Pediatric Patients: Case Series by Bio, Laura L, Brillantes, Marianne

“…ABSTRACTThe weight-based dose of vancomycin has increased for children with red man syndrome (RMS), but the duration of infusion has not. Therefore, there is…”
Get full text

Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce by Willis, Zachary I, Oliveira, Carlos R, Abzug, Mark J, Anosike, Brenda I, Ardura, Monica I, Bio, Laura L, Boguniewicz, Juri, Chiotos, Kathleen, Downes, Kevin, Grapentine, Steven P, Hersh, Adam L, Heston, Sarah M, Hijano, Diego R, Huskins, W Charles, James, Scott H, Jones, Sarah, Lockowitz, Christine R, Lloyd, Elizabeth C, MacBrayne, Christine, Maron, Gabriela M, Hayes McDonough, Molly, Miller, Christine M, Morton, Theodore H, Olivero, Rosemary M, Orscheln, Rachel C, Schwenk, Hayden T, Singh, Prachi, Soma, Vijaya L, Sue, Paul K, Vora, Surabhi B, Nakamura, Mari M, Wolf, Joshua

“…Abstract Background Since November 2019, the SARS-CoV-2 pandemic has created challenges for preventing and managing COVID-19 in children and adolescents. Most…”
Get full text

Variables Affecting Pharmacy Students’ Patient Care Interventions during Advanced Pharmacy Practice Experiences by Bio, Laura L., Patterson, Brandon J., Sen, Sanchita, Bingham, Angela L., Bowen, Jane F., Ereshefsky, Benjamin, Siemianowski, Laura A.

“…Objective. To identify the temporal effect and factors associated with student pharmacist self-initiation of interventions during acute patient care advanced…”
Get full text

Comparison of Linezolid and Daptomycin in the Treatment of Vancomycin-Resistant Enterococcal Bacteremia by Bio, Laura L, Perez, Mirza E, MacDougall, Conan, Gallagher, Jason C

“…OBJECTIVE:To describe the microbiological cure rate and clinical outcomes of linezolid and daptomycin pharmacotherapy in the treatment of vancomycin-resistant…”
Get full text